How will Pharmacogenomics look in 2020? Is your company sufficiently prepared? Join FDA regulatory attorney Darshan Kulkarni as he discusses how pharmacogenomics may change in 2020, and whether your clinical trials may be affected.
Drugmakers have become increasingly entangled in kickback and bribery schemes, and as a consequence, face millions in settlement to the U.S. government.
Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly bribing doctors to prescribe their drugs.
US Food and Drug Administration (FDA) cracks down on false claims--issuing warning letters to companies for marketing supplements as valid treatment options for Alzheimer’s disease.
The Pharmacist was the most trusted profession until that trust was tarnished by fraudulent practices. In this podcast, we discuss those practices.
The Pharmacist was the most trusted profession until that trust was tarnished by fraudulent practices. Let’s examine the top 10 causes of pharmacist fraud!